Effect of Pre-Procedural Beta-Blocker on Clinical Outcome after Percutaneous Coronary Intervention in Acute Coronary Syndrome.

导出 LinkOut

翻译打印收藏纠错

作者： Bum Sung,Kim ^[1] ; Sang-Youg,Eom ^[2] ; Sung Hea,Kim ^[1] ; Hweung Kon,Hwang ^[1] ; Jong-Seon,Park ^[3] ; Weon,Kim ^[4] ; Jun-Won,Lee ^[5] ; Seung-Woon,Rha ^[6] ; Geon Young,Kim ^[7] ; Sang Wook,Lim ^[8] ; Su Hun,Lee ^[9] ; Jei Keon,Chae ^[10] ; Seong-Ill,Woo ^[11] ; Jang-Whan,Bae ^[12] ; Hyun-Joong,Kim ^[1]

作者单位： Division of Cardiology, Department of Internal Medicine, Konkuk University Medical Center, School of Medicine, Konkuk University. ^[1] Department of Preventive Medicine, College of Medicine, Chungbuk National University. ^[2] Division of Cardiology, Department of Internal Medicine, Yeungnam University Hospital. ^[3] Cardiovascular Division, Department of Internal Medicine, Kyung Hee University Hospital. ^[4] Division of Cardiology, Department of Internal Medicine, Wonju Severance Christian Hospital. ^[5] Cardiovascular Center, Korea University Guro Hospital. ^[6] Department of Internal Medicine, Andong Hospital. ^[7] CHA Bundang Medical Center, CHA University. ^[8] Dong Kang Medical Center. ^[9] Division of Cardiology, Chonbuk National University Hospital. ^[10] Department of Cardiology, Inha University Hospital. ^[11] Department of Internal Medicine, Chungbuk National University, College of Medicine. ^[12]

关键词 Cardiac death Coronary artery disease Pre-procedural medication